MedTrace Logo

Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis

NCT06042660 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 527

Last updated 2023-09-18

No results posted yet for this study

Summary

The aim of the retrospective study was to further characterize the prevalence of comorbid conditions as well as the use of concomitant medications in newly diagnosed CML patients in a real-world setting. Hematologists from ten Polish hematological tertiary care centers were asked to analyze medical records for all consecutive CML patients diagnosed with chronic phase CML between January 1st 2005 and December 31st 2014.

Conditions

  • Chronic Myeloid Leukemia

Interventions

OTHER

the prevalence of comorbid conditions

analysis of history of comorbidities at the time of CML diagnosis

Sponsors & Collaborators

  • Polish Adult Leukemia Group

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-07-31
Completion
2016-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06042660 on ClinicalTrials.gov